Abbott Laboratories buy Royal Bank of Canada
Start price
21.01.25
/
50%
€110.84
Target price
21.01.26
€129.42
Performance (%)
2.54%
Price
22:26
€113.66
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 2.54%. This prediction currently runs until 21.01.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | -2.809% | -2.809% |
iShares Core DAX® | -0.081% | -1.435% |
iShares Nasdaq 100 | -0.201% | 1.543% |
iShares Nikkei 225® | 1.465% | 1.838% |
iShares S&P 500 | 0.215% | 1.237% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $135.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€116.00
17.04.25
17.04.25
€127.60
17.04.26
17.04.26
-2.02%
22:26
22:26
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.40
08.10.24
08.10.24
€118.39
08.10.25
08.10.25
9.90%
22:26
22:26
Abbott Laboratories
Start price
Target price
Perf. (%)
€94.80
04.06.24
04.06.24
€114.98
04.06.25
04.06.25
23.76%
05.06.25
05.06.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.67
19.04.24
19.04.24
€117.41
19.04.25
19.04.25
13.67%
20.04.25
20.04.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.16
14.02.24
14.02.24
€119.35
14.02.25
14.02.25
19.97%
15.02.25
15.02.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.54
25.01.24
25.01.24
€118.09
25.01.25
25.01.25
16.23%
26.01.25
26.01.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
6.29%
12.01.25
12.01.25